Ursprung des Netzwerks ersten Grades von Lauren Harshman
| Einheit | Art der Einheit | Industrie | |
|---|---|---|---|
| Subsidiary | Biotechnology | 19 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Lauren Harshman
| Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
|---|---|---|---|
| AMGEN INC. | Pharmaceuticals: Major | Corporate Officer/Principal Comptroller/Controller/Auditor | |
| BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Sales & Marketing Corporate Officer/Principal | |
| ELI LILLY AND COMPANY | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
Oppenheimer & Co., Inc.
 Oppenheimer & Co., Inc. Investment ManagersFinance Oppenheimer & Co., Inc. provides security brokerage services. It also offers investment banking and advice to high net worth investors, individuals, businesses and institutions. The company is headquartered in New York, NY. | Investment Managers | Corporate Officer/Principal | |
| ARENA PHARMACEUTICALS | Pharmaceuticals: Major | Director of Finance/CFO | |
| HALOZYME THERAPEUTICS, INC. | Biotechnology | Director of Finance/CFO Corporate Officer/Principal | |
Protagonist Pty Ltd.
 Protagonist Pty Ltd. Pharmaceuticals: MajorHealth Technology Protagonist Pty Ltd. operates as a clinical-stage biopharmaceutical company. Its proprietary technology platform focused on discovering and developing peptide-based new chemical entities to address significant unmet medical needs. The company was founded on September 19, 2001 and is headquartered in Brisbane, Australia. | Pharmaceuticals: Major | Director/Board Member | |
| SUTRO BIOPHARMA, INC. | Pharmaceuticals: Major | Director/Board Member | |
| AILERON THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member | |
| SHIRE | Pharmaceuticals: Major | Director of Finance/CFO | |
| ASTRIA THERAPEUTICS, INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Symic Bio, Inc.
 Symic Bio, Inc. BiotechnologyHealth Technology Symic Bio, Inc. develops new category of therapeutics. The company studies treatments for osteoarthritis and cardiovascular ailments. The firm developed a new therapeutic category of bioconjugates that directly target the extracellular matrix, the biologically active environment which plays critical roles for cell proliferation, migration, differentiation and survival. The company was founded by Kate Stuart and John Paderi in 2012 and is headquartered in San Francisco, CA. | Biotechnology | Chairman | |
| SPYRE THERAPEUTICS, INC. | Biotechnology | Chairman Director/Board Member | |
Wylei, Inc.
 Wylei, Inc. Packaged SoftwareTechnology Services Wylei, Inc. develops cloud-based automated engagement technologies for digital direct marketing. The firm offers behavioral tracking and analysis through web, mobile, and email; market research studies; automated customer preference detection; emails to the moment of open; animated countdown timers and device-centric formatting. The company was founded by Ken Kozaczka in 2013 and is headquartered in Jersey City, NJ. | Packaged Software | Director/Board Member | |
Symic Holdings LLC
 Symic Holdings LLC BiotechnologyHealth Technology Symic Holdings LLC develops new category of therapeutics. The company was founded by John Paderi, Kate Stuart and Alyssa Panitch and is headquartered in Emeryville, CA. | Biotechnology | Director/Board Member | |
| Stanford University | College/University | Undergraduate Degree Undergraduate Degree | |
| Harvard Medical School | College/University | Doctorate Degree Graduate Degree Graduate Degree | |
| BLUEBIRD BIO, INC. | Biotechnology | Corporate Officer/Principal Director/Board Member Director/Board Member | |
Atlas Venture Advisors, Inc.
 Atlas Venture Advisors, Inc. Investment ManagersFinance Atlas Venture Advisors Inc (Atlas Venture Advisors) is a venture capital firm founded in 1980 by Christopher Julian Spray. The firm is headquartered in Cambridge, Massachusetts. | Investment Managers | Private Equity Investor Consultant / Advisor Consultant / Advisor | |
| INFINITY PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
Affinia Therapeutics, Inc.
 Affinia Therapeutics, Inc. BiotechnologyHealth Technology Affinia Therapeutics, Inc. is a preclinical stage company, which engages in the research and development of gene therapy. It offers Affinia Rationally-designed Therapies (ART) platform, which develops novel therapies, focusing on the key components of a gene therapy: capsids, which are the outer shells of a virus used to package the genetic code to treat a disease; promoters, which control how the cells read the genetic code that is delivered; and manufacturing approaches, which determine the quality and cost of potential medicines. The company was founded by Luk Vandenberghe, Botond Roska, and Aaron Tward in 2019 and is headquartered in Waltham, MA. | Biotechnology | Director/Board Member Director/Board Member | |
| XILIO THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| 2SEVENTY BIO, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| MIRATI THERAPEUTICS | Biotechnology | Director of Finance/CFO Corporate Officer/Principal | |
| The University of Chicago | College/University | Doctorate Degree Doctorate Degree | |
| Abshanafelt Advisory | President | ||
| UCLA Anderson School of Management | College/University | Masters Business Admin | |
| Columbia University College of Physicians & Surgeons | College/University | Graduate Degree | |
Obsidian Therapeutics, Inc.
 Obsidian Therapeutics, Inc. BiotechnologyHealth Technology Obsidian Therapeutics, Inc. develops cell and gene therapeutics that employ precise exogenous control of transgenes for improved safety and efficacy. The company was founded in 2016 and is headquartered in Cambridge, MA. | Biotechnology | Director/Board Member | |
| Arizona State University | College/University | Undergraduate Degree | |
| SERES THERAPEUTICS, INC. | Biotechnology | Corporate Officer/Principal | |
Shire, Inc.
 Shire, Inc. Pharmaceuticals: MajorHealth Technology Part of Takeda Pharmaceutical Co., Ltd., Shire, Inc. develops and markets medicines for patients with rare diseases. The company is based in Lexington, KY. | Pharmaceuticals: Major | Public Communications Contact | |
| PMV PHARMACEUTICALS, INC. | Miscellaneous Commercial Services | Director/Board Member | |
| LONGBOARD PHARMACEUTICALS, INC. | Biotechnology | Director/Board Member | |
| Harvard College | College/University | Undergraduate Degree | |
| PROTAGONIST THERAPEUTICS, INC. | Biotechnology | Director/Board Member | |
| Holy Cross College (Indiana) | College/University | Undergraduate Degree | |
Apple Tree venture Managemnet Llc//vc
 Apple Tree venture Managemnet Llc//vc Investment ManagersFinance Apple Tree venture Managemnet LLC (Apple Tree Partners) is a venture capital firm founded by Seth Harrison in 1999. The firm is headquartered in New York with an additional offices in London, San Francisco and Cambridge. | Investment Managers | Director of Finance/CFO | |
The Lek/Alcar Consulting Group, Inc.
 The Lek/Alcar Consulting Group, Inc. Miscellaneous Commercial ServicesCommercial Services The Lek/Alcar Consulting Group, Inc. provides business strategy consulting services. It offers strategy, finance, marketing and sales, operations, and transaction services including business unit strategy, brand management, pricing, alliances and joint ventures, product development, corporate transformation, and operations design. It serves the defense, energy, health, building and construction, aerospace, media, retail, and telecommunications industries. The company was founded by Andrew Kutter in 1983 and is headquartered in Boston, MA. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
| The Wharton School of the University of Pennsylvania | College/University | Masters Business Admin | |
Baxter BioScience Corp.
 Baxter BioScience Corp. BiotechnologyHealth Technology Baxter BioScience Corp. provides biopharmaceutical and vaccines services. It offers a portfolio of therapeutic proteins derived from either human plasma or recombinant technology. The company is headquartered in Beltsville, MD. | Biotechnology | Corporate Officer/Principal | |
| KARA THER | Pharmaceuticals: Major | Director/Board Member | |
| University of Colorado Boulder | College/University | Undergraduate Degree |
Statistik
International
| Vereinigte Staaten | 44 |
| Australien | 2 |
| Irland | 2 |
| Vereinigtes Königreich | 2 |
Sektoral
| Health Technology | 29 |
| Consumer Services | 11 |
| Finance | 4 |
| Commercial Services | 4 |
| Technology Services | 2 |
Operativ
| Director/Board Member | 74 |
| Corporate Officer/Principal | 47 |
| Independent Dir/Board Member | 33 |
| Undergraduate Degree | 17 |
| Chief Executive Officer | 15 |
Am stärksten vernetzte Beziehungen
| Insiders | |
|---|---|
| Dave Grayzel | 23 |
| Charles Sigal | 20 |
| Denice Torres | 19 |
| J. Goater | 17 |
| Armen Shanafelt | 17 |
| Laurie Stelzer | 13 |
| Vito Palombella | 11 |
| Cameron McDonough | 11 |
| Carsten Brunn | 10 |
| Alison O'Neill | 10 |
| Benjamin Hickey | 9 |
| Henry Rath | 9 |
| Jessica Fees | 8 |
| Ramy Ibrahim | 8 |
| Robert Ross | 7 |
- Börse
- Insiders
- Lauren Harshman
- Unternehmensverbindungen
